Short-term teriparatide treatment does not affect NT-proBNP, a marker of cardiac disease

By Ellegaard Maria   Schwarz Peter   Hansen Caroline R.   Faber Jens   Vestergaard Henrik  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 72, Iss. 7, 2012-11 ,pp. : 518-522

Informa Healthcare

Access to resources Recommend Favorite

COPD and Cardiac Death: Pressure (NT-proBNP), Inflammation (CRP) or Both?

By  

Respiration, Vol. 79, Iss. 5, 2010-01 ,pp. : 353-354

Karger

Access to resources Recommend Favorite

Analysis of peptides derived from Pro Atrial Natriuretic Peptide that circulate in man and increase in heart disease

By Macaulay Hunter E F   Kelly P A   Prowse C   Woods R J   Lowry P J  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 58, Iss. 3, 1998-07 ,pp. : 205-216

Informa Healthcare

Access to resources Recommend Favorite

Impact of growth hormone (GH) treatment on circulating Nt-proBNP concentrations and on cardiac function in adult GH-deficient patients

By Gruson Damien   Alexopoulou Orsalia   Pasquet Agnès   Cumps Jean   Ketelslegers Jean-Marie   Maiter Dominique  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 72, Iss. 5, 2012-09 ,pp. : 387-394

Informa Healthcare

Access to resources Recommend Favorite

NT-proBNP for Pulmonologists: Not Only a Rule-Out Test for Systolic Heart Failure but Also a Global Marker of Heart Disease

By  

Respiration, Vol. 77, Iss. 4, 2009-03 ,pp. : 370-380

Karger

Access to resources Recommend Favorite